Synopsis of the 2017 US Department of Veterans Affairs/US Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus
Synopsis of the 2017 US Department of Veterans Affairs/US Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus
复制标题
DOI：
10.7326/m17-1362
复制
发表时间：
2017-11-07
影响因子：
39.2
通讯作者：
Pogach, Leonard
中科院分区：
文献类型：
--
作者：
Conlin, Paul R.;Colburn, Jeffrey;Pogach, Leonard
2017年4月，美国退伍军人事务部（VA）和美国国防部（DoD）批准了2型糖尿病管理的联合临床实践指南。方法：VA/DoD循证实践工作组召集了VA/DoD联合指南制定工作，其中包括执业临床医生利益相关者的多学科小组，并符合医学研究所关于可信赖临床实践指南的原则。指南小组与ECRI研究所合作制定了关键问题，该研究所系统地检索和评估了截至2016年6月的文献，开发了一种算法，并通过使用GRADE（建议评估、发展和评估分级）系统对建议进行评级。建议：本摘要总结了该指南在7个方面的主要特点：以患者为中心的护理和共同决策、血糖生物标志物、血红蛋白A1c目标范围、个性化治疗计划、门诊药物治疗、危重患者的血糖目标和住院患者的治疗。
Description: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U. S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus.Methods: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included a multidisciplinary panel of practicing clinician stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions in collaboration with the ECRI Institute, which systematically searched and evaluated the literature through June 2016, developed an algorithm, and rated recom-mendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system.Recommendations: This synopsis summarizes key features of the guideline in 7 areas: patient-centered care and shared decision making, glycemic biomarkers, hemoglobin A1c target ranges, individualized treatment plans, outpatient pharmacologic treatment, glucose targets for critically ill patients, and treatment of hospitalized patients.